1 Product identity
Ingredient risk
Contains restricted ingredients

ლიბო მაქსი კაფსულები

BrandHerbalhealing→მამაკაცის ჰორმონალური ბალანსი და ლიბიდოს მხარდაჭერა 5 ingredients 1 banned 1 caution Source: herbalhealing.ge ↗
DSLD entry: 2026-06-02
2 Ingredients (5)
IngredientGroupSafety
AshwagandhaAshwagandhaBanned in ≥1 country
CinnamonCinnamonUse with Caution
TribulusTribulusLimited Evidence
ShatavariShatavariConditionally Safe
Tribulus TerrestrisTribulus TerrestrisLimited Evidence
Ingredient details from the manufacturer listing. View product at herbalhealing.ge →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha  🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Cinnamon  🇪🇺 — Coumarin TDI 0.1 mg/kg BW/day. Cassia type exceeds limits at typical supplement doses.
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Cinnamon — Use with Caution
⚠ Cassia: high coumarin (hepatotoxic)
⚠ May lower glucose
Tribulus — Limited Evidence
⚠ Liver and kidney toxicity case reports
⚠ Hormonal claims poorly supported
Shatavari — Conditionally Safe
⚠ Estrogenic activity
⚠ May worsen kidney disorders (oxalate)
Tribulus Terrestris — Limited Evidence
⚠ Liver and kidney toxicity case reports
⚠ Hormonal claims poorly supported
5 Data source
DSLD ID900000030
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2026-06-02
6 More from Herbalhealing
View Herbalhealing Safety Scorecard → 24 products
C მაქსი (ამლა) კაფსულებიალოე ვერას კაფსულებიაშვაგანდას კაფსულებიბრაჰმის კაფსულებიდარიჩინის და მიხაკის კაფსულებიიმუნო ლაიფი
7 Cite this page
Vancouver
Pkhakadze G. ლიბო მაქსი კაფსულები — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/%e1%83%9a%e1%83%98%e1%83%91%e1%83%9d-%e1%83%9b%e1%83%90%e1%83%a5%e1%83%a1%e1%83%98-%e1%83%99%e1%83%90%e1%83%a4%e1%83%a1%e1%83%a3%e1%83%9a%e1%83%94%e1%83%91%e1%83%98-900000030/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG